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The chemical warfare agent analog, 2-chloroethyl ethyl sulfide, known as ‘half-mustard gas’ (HMG), is less
toxic and less of an environmental hazard than the full molecule and has been shown to produce an acute lung
injury in rats when instilled via intrapulmonary injection. This injury is characterized by massive, localized
hemorrhage and edema into the alveolar compartment and can be quantitated by measuring extravasation of
125I-bovine serum albumin into the extravascular compartment. Employing this rat model of HMG-induced
lung injury, we observed significant attenuation of the pulmonary injury when experimental animals were
complement or neutrophil depleted prior to HMG challenge. Significant protection also was provided by
the use of antioxidants such as catalase, dimethyl sulfoxide, dimethyl thiourea, resveratrol and N-acetyl-
L-cysteine (NAC). The last compound showed protection from lung injury as high as 70% and was still
effective even when given up to 90 min after exposure of the lungs to HMG. These data suggest that acute
lung injury caused by exposure to HMG may be related partially to complement mediated pathways and
the generation by neutrophils of toxic oxygen species The data indicate that NAC is an effective antidote
against HMG-induced acute lung injury in the rat. Copyright  2002 John Wiley & Sons, Ltd.
INTRODUCTION
Mustard gas [bis (2-chloroethyl) sulfide, also known as
sulfur mustard (HD)] was first synthesized in the early to
mid-1800s.1 It is an oily liquid and is a lipophilic alkylat-
ing agent that, when absorbed, causes chemical reactions
with cellular components, resulting in cytotoxic effects.1 – 6
Mustard agents are most commonly described as vesi-
cating or blistering agents, owing to the fact that the
wounds most often seen in HD exposure resemble burns
and blisters. Mustard agents can be described more accu-
rately as vesicating and tissue-damaging agents because
of the severe widespread damage to the lungs,7,8 internal
organs9 – 12 and eyes,13 as well as to the skin.14,15 Mustard
gas also has been described as radiomimetic, carcinogenic,
teratogenic and mutagenic.16 – 19 It has been used recently
in chemical attacks against the Iranians during the Gulf
War of 1984–1985 and by the Iraqis in 1988 against their
own Kurdish population.6,20 Unfortunately, there is no
effective treatment for HD intoxication. Decontamination
of HD immediately after contact is still the recommended
treatment.1,6
In addition to skin, the lungs and respiratory tract
are among the most commonly affected organs, with
effects that can be both acute (owing to its vesicating
action) and long term (including airway hyperreactivity,
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chronic bronchitis, asthma, bronchiectasis and pulmonary
fibrosis).17,18 Complications due to HD exposure also can
include hemorrhagic inflammation, erosion and effects on
the lung parenchyma.17,18,21 – 23 There has been only a lim-
ited number of animal studies investigating HD-induced
lung injury. Calvet et al.21 – 23 have described the develop-
ment of peribronchial edema and bronchoconstriction in
guinea pigs, whereas Vijayaraghavan et al.19,24 have stud-
ied the changes in breathing patterns caused by inhaled or
percutaneous exposure to HD in mice and rats.
A rat lung injury model has been established in our
laboratory to study the effectiveness of complement and
neutrophil depletion as well as treatment with antioxidants
in attenuating injury caused by intrapulmonary instillation
of half-mustard gas (HMG). Based on our long-standing
experience with experimental pulmonary injury models
in the rat,25 – 27 we have chosen this species to study
the pathogenesis of HMG (2-chloroethyl ethyl sulfide)-
induced acute lung injury. Half-mustard gas is the standard
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Animals
Adult male (275–325 g) specific-pathogen-free Long-
Evans rats (Harlan Co., Indianapolis, IN) were used in
these studies. Intraperitoneal ketamine (100 mg kg−1 body
weight) (Fort Dodge Animal Health, Fort Dodge, IA) was
used for continuous anesthesia and sedation (4 h). After
induction of anesthesia, 125I-labeled bovine serum albumin
([125I]BSA, 0.5 µCi per rat) was injected intravenously as
a quantitative marker for vascular permeability. The tra-
chea then was surgically exposed and a slightly curved
catheter was inserted into the trachea past the bifurcation
to facilitate a unilateral, left-lung injury. A small volume
of HMG (2 µl per rat) was solubilized in ethanol (58 µl
per rat) and then added to a syringe containing Dulbecco’s
phosphate-buffered saline (DPBS) (340 µl per rat). This
solution was injected via the intratracheal catheter, caus-
ing a unilateral lung injury. Studies not requiring the use
of a radiolabeled marker proceeded identically, substitut-
ing DPBS for the radioactive injection. For all studies,
except the time response experiment, animals were sacri-
ficed 4 h later, the pulmonary circulation was flushed with
10 ml of cold DPBS, the lungs were surgically dissected
and placed in counting vessels and the amount of radioac-
tivity ([125I]BSA) was determined by gamma counting.
For calculations of the permeability index, the amount of
radioactivity ([125I]BSA) remaining in the lungs in which
the vasculature was perfused with saline was divided by
the amount of radioactivity present in 1.0 ml of blood
obtained from the posterior vena cava at the time of sac-
rifice.
All animal experiments were in accordance with the
standards in ‘The Guide for the Care and Use of Labora-
tory Animals’ and were supervised by veterinarians from
the Unit for Laboratory and Animal Care of the University
of Michigan Medical School.
Neutrophil depletion
Neutrophil depletion was induced by intraperitoneal injec-
tion of 1.0 ml of rabbit anti-serum to rat polymor-
phonuclear neutrophils PMNs (Accurate, Westbury, NY).
Twenty-four hours later, peripheral venous blood was
obtained from the tail vein and analyzed for total neu-
trophil counts. The antibody reduced the number of neu-
trophils in peripheral blood by >90%.25
Complement depletion
Cobra venom factor (CVF) was purified from crude,
lyophilized cobra venom (Naja atra) by ion exchange
chromatography.28 Complement depletion of experimental
animals was achieved by intraperitoneal injections of 25
units of CVF per rat at time zero and 24 h later, resulting
in undetectable levels of serum hemolytic complement
activity as confirmed by CH50 assay.26 Experiments were
performed 24 h after the second CVF injection.
Antioxidants
The dosing of the antioxidant compounds used in the
present study has proved effective in other rat mod-
els of acute lung injury that were also dependent on
blood neutrophils and complement.25,29,30 The following
antioxidant compounds were tested separately and given
intraperitoneally 10 min prior to intrapulmonary instilla-
tion of HMG: dimethyl thiourea (DMTU) (1000 mg kg−1
body wt. in 1.0 ml of sterile DPBS), dimethyl sulfox-
ide (DMSO) (1.5 ml kg−1 body wt in 1.0 ml of sterile
DPBS); catalase (2 50 000 units per rat in 2.0 ml of sterile
DPBS); and resveratrol (50 mg kg−1 body wt in 0.5 ml of
propylene glycol).
N-Acetyl-L-cysteine (NAC) was administered intra-
venously in varying concentrations and at different time
points throughout the course of the HMG injury to estab-
lish both time and dose response data. The iron chela-
tor—2,3-dihydroxybenzoic acid (100 mg kg−1 body wt in
0.5 ml of DPBS) or deferoxamine mesylate (15 mg kg−1
body wt in 0.5 ml of DPBS)—was injected intravenously
10 min prior to HMG instillation. As mentioned above,
all chemicals were purchased from Sigma Chemical Co.
(St. Louis, MO).
Statistical analysis
Results are presented as mean ± SEM in the text and
figures. Groups (n = 5) were subjected to one-way analy-
sis of variance and when significance was found Student’s
t-test with the Bonferroni correction for multiple compar-
isons was applied. A value of P < 0.05 was considered
significant.
RESULTS
Dose and time dependency of HMG- induced lung
injury
A lung injury model was developed in the rat using HMG
in our laboratory (for details, see above). Extravasation
of [125I] BSA was used as a measure of tissue damage
in the lung 4 h after HMG injection. A dose response
experiment was run over a period of 4 h. Animals treated
included a group of controls and groups of animals treated
intrapulmonary with 3, 6, 9 or 12 mg HGM kg−1 body
wt. The results are shown in Fig. 1. The control group
(intrapulmonary injection of the vehicle only) produced a
background permeability value of 0.25 ± 0.03. Treatments
with 3, 6, 9 or 12 mg of HMG yielded lung permeabil-
ity indices of 0.97 ± 0.17, 1.92 ± 0.17, 2.00 ± 0.31 and
2.23 ± 0.16, respectively. From the dose response stud-
ies, the dosage of 6 mg kg−1 (about 2 mg of HMG per
rat) was selected. All the subsequent experiments used
this concentration of HMG.
A time dependency experiment was run after determin-
ing the optimal dosage of HMG. When lung injury values
were determined at 2, 4 and 6 h after HMG instillation into
the lungs, injury values of 0.76 ± 0.19, 1.92 ± 0.17 and
4.08 ± 0.19, respectively, were obtained (Fig. 2). These
studies indicated an almost linear increase in injury dur-
ing the first 4 h of injury and confirmed the suitability of
the 4-h time point for our studies. Unless otherwise noted,
the 4-h time point following exposure to HMG was used,
because previous studies with acute lung injury employed
the same time point.
Protective effects of neutrophil depletion
Blood neutrophil depletion (<250 neutrophils µl−1 blood)
was induced by the injection of a rabbit anti-rat PMN
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Figure 1. Dose-dependent increases in acute pulmonary injury
(lung injury values defined by the permeability index) in the
rat caused by HMG. Lung injury was determined at 4 h after
intrapulmonary HMG injection. Based on these observations,
6 mg HMG kg−1 body wt was chosen for all subsequent
experiments. ∗Significant changes compared with reference
value and n = 5 for each bar, for this and all subsequent figures.
Figure 2. Time-dependent increases in lung injury values
following intrapulmonary HMG (6 mg kg−1) injection into rats.
Based on these observations, lung injury was determined in
subsequent studies at 4 h post-HMG injection.
antibody as described above. 125I-Labeled BSA extrava-
sation was used as a measure of tissue damage in the
lung 4 h after the HMG instillation. Protection was cal-
culated after subtracting the negative control values from
the positive controls and lung injury values obtained from
experimental animals. The results of neutrophil depletion
on HMG-induced lung injury are shown in Fig. 3. As
can be seen, neutrophil depletion was associated with a
62% reduction in HMG-induced lung injury (neutrophil-
depleted rats showed a mean permeability index of 0.88 ±
0.07, compared with a value of 1.92 ± 0.17 for non-
neutropenic rats). This indicates that full development of
the HMG-induced lung injury requires the availability of
neutrophils.
Protective effects of complement depletion
Complement depletion was achieved by the serial
intraperitoneal administration of CVF as described
above. The results of complement depletion on vascular
permeability are illustrated in Fig. 3. Depletion of
complement resulted in a 43% reduction in lung injury
(complement-depleted rats had a permeability index of
1.21 ± 0.05, compared with a value of 1.92 ± 0.17 for
non-depleted rats). These observations indicate that full
development of the HMG-induced lung injury is, at least
in part, complement dependent.
Protection by antioxidants
The dosing of the antioxidant compounds used in the
present study (see above) has proved effective in other
rat models of acute lung injury that were also dependent
on blood neutrophils and complement.25 – 27 The results
of these interventional studies in the HMG model are
depicted in Fig. 4. The DMSO treatment resulted in a
51% reduction of the observed positive control injury
(DMSO administration showed a lung injury value of
1.07 ± 0.013, compared with a value of 1.92 ± 0.17
for non-treated rats). The DMTU afforded a 38% pro-
tective effect (mean lung injury value = 1.29 ± 0.02).
Catalase treatment resulted in a 47% protective effect
(lung injury value = 1.13 ± 0.14). Treatment with resver-
atrol—a phytoalexin and one of several antioxidants
found in wine31,32 —resulted in a 61% reduction in HMG-
induced lung injury (mean lung injury value = 0.91 ±
0.03). The iron chelators 2,3 dihydroxybenzoic acid
(DHBA) and deferoxamine mesylate (desferal) showed no
significant protection.
In summary, significant reductions in lung injury were
seen when catalase, the hydroxyl radical scavengers
(DMSO and DMTU) and resveratrol were given. Superox-
ide dismutase (SOD), 2,3-dihydroxybenzoic acid (DHBA)
Figure 3. Intrapulmonary HMG injection into complement (C)-
depleted or neutrophil (PMN)-depleted rats.
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Figure 4. Effect of various antioxidants on HMG-induced acute
lung injury. Test compounds included iron chelators, [desferal
and 2,3-dihydroxybenzoic acid (DHBA)], antioxidant enzymes
[catalase and superoxide dismutase (SOD)], hydroxyl radical
scavengers [dimethyl thiourea (DMTU) and dimethyl sulfoxide
(DMSO)] and a phytoalexin (resveratrol), which can also display
antioxidative effects. For further details, see text.
and desferal showed no protective effects (Fig. 4). These
observations support the concept of toxic oxygen species
in the pathogenesis of HMG-induced acute lung injury.
N-Acetyl-L-cysteine (NAC) dose responses and time
dependency
N-Acetyl-L-cysteine was also tested and demonstrated
highly protective effects against HMG-induced lung injury
(see data below). A dose response for intravenously
administered NAC was generated for the 4-h HMG injury.
All doses of NAC were given 10 min prior to instil-
lation of the HMG. The NAC was used at doses of
5, 10, 20, 30 and 40 mg kg−1 body wt. The treatment
groups at 4 h showed lung injury values of 1.53 ± 0.06
at 5 mg kg−1, 1.18 ± 0.09 at 10 mg kg−1, 0.75 ± 0.10 at
20 mg kg−1, 1.06 ± 0.06 at 30 mg kg−1 and 0.99 ± 0.08
at 40 mg kg−1 (Fig. 5). These data showed significant pro-
tection for all NAC doses tested, the highest being 70% for
a NAC dose of 20 mg kg−1 (Fig. 5). From this experiment
the optimum intravenous dosage of NAC was determined
to be 20 mg kg−1 body wt.
The time course studies for the effectiveness of NAC
treatments used the optimum dosing (20 mg kg−1 body wt
i.v.) administered at various time points throughout the
course of the injury. The treatment time points included
the previously used 10 min prior to injury as well as
administration of NAC 10, 30, 60, 90, 120 and 180 min
after the instillation of HMG (Fig. 6). The 4-h lung
injury values after HMG instillation were 1.23 ± 0.02
when NAC was given at 10 min, 0.99 ± 0.02 at 30 min,
1.11 ± 0.10 at 60 min, 1.02 ± 0.15 at 90 min, 1.64 ±
0.14 at 120 min and 2.04 ± 0.30 at 180 min. These lung
injury values translated into a 42% protection when NAC
was given 10 min after HMG and rose to 56% and
49% protection for the 30-min and 60-min time points,
respectively. Even when NAC treatment was administered
as late as 90 min after HMG exposure, there was still a
54% reduction in lung injury. No significant changes were
observed when NAC treatment was delayed by >90 min
(Fig. 6).
Figure 5. Dose-dependent protective effects of NAC on HMG-
induced lung injury; NAC was injected 10 min prior to HMG.
Lung injury values were determined at 4 h post-HMG injection.
Figure 6. Effect of delayed NAC (20 mg kg−1) treatment of HMG-
injected rats.
DISCUSSION
To elucidate the pathogenic mechanisms involved in the
development of HM-induced lung injury and to assess
promising therapeutic interventions, a new rat model of
HMG-induced acute pulmonary injury has been devel-
oped. Employing this model, experimental data have been
obtained that strongly suggest that the HMG-induced
acute (4-h) lung injury requires a fully functioning com-
plement system and the availability of blood neutrophils.
Complement or neutrophil depletion of experimental ani-
mals prior to HMG challenge resulted in 40% and
60% protection from lung injury, respectively. These are
new findings for this type of acute lung injury. Ander-
son et al. found increased numbers of neutrophils in
bronchoalveolar lavage fluids of HD-treated rats.33 In
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chronic lung injury of patients exposed to mustard gas,
neutrophilic alveolitis was described as a predominant
feature.34 The early appearance of neutrophils in HD-
induced skin lesions is well established.35 Although serum
complement consumption by HD in vitro was reported in
1946,36 and increased in vitro binding of Clq to HD-treated
keratinocytes has been reported recently,37 the pathogenic
role of complement in HD-induced organ injury remains
a matter of speculation. It is assumed that complement
activation products may participate in the pathogenesis of
HMG-induced lung injury by stimulating neutrophils and
other blood and organ cells.
Because other animal models of neutrophil- and
complement-dependent acute lung injury have shown that,
at least in part, toxic oxygen species are participating
in the pathogenesis,25,29,38 the effect on HMG-induced
lung injury of various antioxidants was investigated.
As shown in Fig. 4, catalase, the hydroxyl radical
scavengers (dimethyl thiourea and dimethyl sulfoxide)
and the phytoalexin (resveratrol) all exhibited pronounced
protection from HMG lung injury. Superoxide dismutase
(SOD) reduced lung injury by 23%, but these changes
were not significant. Eldad et al.,39 using a guinea
pig model of HD-induced skin burns, saw significant
reductions in the skin lesions when SOD was given
intraperitoneally or intralesionally 1 or 3 h in advance
of wound infliction. No protection was seen when SOD
was given 1 h after skin exposure. We also tested
iron chelators, which have shown strong protection in
other models of oxidant-induced lung injury.30,40 Why
desferal (deferoxamine) and 2,3-dihydroxybenzoic acid
(DHBA) did not show any protective effect remains
unclear at present. Nevertheless, oxidants appear to play
a role in HMG-induced lung injury. Our observations
are corroborated by a recently published study by
Kumar et al.,7 who demonstrated that antioxidants such as
vitamin E, quercetin and reduced glutathione (GSH) could
enhance survival time and protect lungs from oxidative
damage in mice exposed to HD.
Additional support for an involvement of oxidants in
the pathogenesis of HMG-induced acute lung injury was
provided by the dramatic effects seen after treatment
of experimental animals with NAC. Not only did NAC
demonstrate the most pronounced protection from lung
injury (Fig. 5), but it also provided significant protec-
tion even when given as late as 90 min after intrapul-
monary injection of HMG (Fig. 6). This protection after
onset of the injury was not seen with any of the other
antioxidants used in our study (data not shown). Others
have observed decreased numbers of neutrophils in bron-
choalveolar lavage fluids obtained from HD-injured lungs
of rats that were treated intraperitoneally with NAC at the
beginning of the experiment.41 The mechanisms of NAC-
mediated protection from mustard-induced lung injury are
not clear. Recent data by Atkins and colleagues42 seem
to suggest that NAC protects from HD-induced apop-
totic endothelial cell death by enhancing the synthesis of
reduced glutathione, which in turn may scavenge HD and
also prevent oxidative activation of the transcription fac-
tor NF-kappa-B, which is usually upregulated by stress
signals.
In summary, our observations suggest that the devel-
opment of HMG-induced lung injury is dependent on
the availability of both neutrophils and complement,
and is largely mediated by toxic oxygen metabolites.
The latter is supported by our findings that NAC, a
well-known antioxidant, has powerful protective effects
related to the dose administered and the time of its
administration.
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